Project 2 The focus of Project 2 of this Program Project is to achieve a fully permissive replication system and detailed molecular understanding of host and viral functions that control human norovirus (HuNoV) replication. For almost 50 years, the most significant barrier to HuNoV research was the lack of an efficient in vitro cell cultivation system. We recently succeeded in establishing a robust and reproducible cultivation system for many HuNoV strains in human stem cell-derived intestinal enteroids (HIEs) that overcomes the longstanding hurdle to cultivation. Strain-specific differences in replication were discovered and the system is being used to study virus neutralization, antiviral activity and HuNoV biology. The goal of Project 2 is to continue to understand and overcome newly recognized remaining barriers in the cultivation of all HuNoVs in HIEs. We will address this goal through two aims that outline studies to (i) continue to improve and simplify the cultivation system by understanding virus entry into cells and (ii) identify the cellular receptor(s) for HuNoVs (Aim 1), and (iii) understand the molecular mechanisms by which norovirus replication induces and regulates cellular innate responses and how these cellular responses restrict viral replication and spread (Aim 2). Therapeutics and host molecules associated with disease and virus clearance (Project 1), and structural insight into viral-host interactions (Project 3) will be tested for their effects on HuNoV replication. Overall, these studies are designed to lead to a fully permissive, simple and affordable replication system, gain new molecular understanding of host and viral functions that control virus replication and provide new insight about HuNoV biology. The program project brings together a highly collaborative group of investigators with diverse skills and talents, and substantial record of working together. As in the previous funding period, the interactions among each project and each of the cores will be extensive such that the activities of each project will be enhanced considerably over what could be accomplished if the projects were pursued independently.
| Alvarado, Gabriela; Ettayebi, Khalil; Atmar, Robert L et al. (2018) Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses. Gastroenterology 155:1898-1907 |
| Costantini, Veronica; Morantz, Esther K; Browne, Hannah et al. (2018) Human Norovirus Replication in Human Intestinal Enteroids as Model to Evaluate Virus Inactivation. Emerg Infect Dis 24:1453-1464 |
| Bányai, Krisztián; Estes, Mary K; Martella, Vito et al. (2018) Viral gastroenteritis. Lancet 392:175-186 |
| Zou, Winnie Y; Blutt, Sarah E; Crawford, Sue E et al. (2017) Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections. Methods Mol Biol : |
| Yu, Huimin; Hasan, Nesrin M; In, Julie G et al. (2017) The Contributions of Human Mini-Intestines to the Study of Intestinal Physiology and Pathophysiology. Annu Rev Physiol 79:291-312 |
| Hurwitz, Amy M; Huang, Wanzhi; Kou, Baijun et al. (2017) Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses. PLoS One 12:e0170162 |
| Cortes-Penfield, Nicolas W; Ramani, Sasirekha; Estes, Mary K et al. (2017) Prospects and Challenges in the Development of a Norovirus Vaccine. Clin Ther 39:1537-1549 |
| Ramani, Sasirekha; Neill, Frederick H; Ferreira, Jennifer et al. (2017) B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol 24: |
| Hurwitz, Amy M; Huang, Wanzhi; Estes, Mary K et al. (2017) Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus. Protein Eng Des Sel 30:129-139 |
| Sharma, Sumit; Carlsson, Beatrice; Czakó, Rita et al. (2017) Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades. J Virol 91: |
Showing the most recent 10 out of 98 publications
